CYP19A1 and breast carcinoma: Adjuvant therapies such as radiation, tamoxifen, aromatase inhibitors (AIs), and chemotherapy improve the prognosis, but also confer a risk of adverse side effects (Early breast cancer trialists' collaborative group, 2005; Forbes et al, 2008).